Sonoma Pharmaceuticals
SNOA
#10129
Rank
NZ$11.46 M
Marketcap
$7.09
Share price
9.59%
Change (1 day)
32.08%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2024 (TTM): -NZ$7.46 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are NZ$13.97 Million. a decrease over its 2023 earnings that were of -NZ$7.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$7.49 Million0.54%
2023 -NZ$7.45 Million-31.5%
2022 -NZ$10.87 Million16.86%
2021 -NZ$9.3 Million194.32%
2020 -NZ$3.16 Million-58.76%
2019 -NZ$7.67 Million-65.66%
2018 -NZ$22.31 Million4.84%
2017 -NZ$21.28 Million-2.17%
2016 -NZ$21.76 Million32.12%
2015 -NZ$16.47 Million-307.74%
2014 NZ$7.92 M-197.5%
2013 -NZ$8.13 Million
2010 -NZ$12.71 Million-14.02%
2009 -NZ$14.78 Million-57.28%
2008 -NZ$34.58 Million-8.03%
2007 -NZ$37.6 Million3.85%
2006 -NZ$36.2 Million39.31%
2005 -NZ$25.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$30.45 Million 306.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$17.38 Million 132.20%๐Ÿ‡บ๐Ÿ‡ธ USA